XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash $ 17,256 $ 6,219
Prepaid expenses, deposits, and other current assets 1,685 328
Total current assets 18,941 6,547
Other assets 837 693
Total assets 19,778 7,240
Current liabilities:    
Accounts payable 2,966 2,353
Accrued expenses and other current liabilities 2,325 1,386
CARES Act Paycheck Protection Program note payable 300
Senior Secured Convertible Notes - at fair value 10,060 8,139
Senior Convertible Note - at fair value 4,600
Total liabilities 20,251 11,878
Commitments and contingencies (Note 7)
Stockholders' Equity (Deficit):    
Common stock, $0.001 par value. Authorized, 150,000,000 shares; issued and outstanding, 63,819,935 shares at December 31, 2020 and 40,478,861 shares at December 31, 2019 64 41
Additional paid-in capital 87,570 47,554
Accumulated deficit (88,275) (53,715)
Total PAVmed Inc. Stockholders' Equity (Deficit) 1,896 (3,824)
Noncontrolling interests (2,369) (814)
Total Stockholders' Equity (Deficit) (473) (4,638)
Total Liabilities and Stockholders' Equity (Deficit) 19,778 7,240
Series B Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit):    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,228,075 at December 31, 2020 and 1,158,209 shares at December 31, 2019 $ 2,537 $ 2,296